One of the largest Certified Spravato Treatment Center in DFW
Over 9,000 Spravato treatment sessions safely conducted
Joint Commission accredited - demonstrating the highest standard in healthcare
Double Board-certified Psychiatrist on site
Knowledgeable , experienced and dedicated Spravato team
Private treatment rooms
Comprehensive Initial Evaluations
Close monitoring and supervision during treatments
Clean and inviting atmosphere
Timely insurance approvals
“Insurance coverage of SPRAVATO/esketamine now allows this life-saving treatment to be accessible to patients that need it"
Shahla Ali, MD, Allen Psychiatry
"I am very satisfied with my treatments and Dr. Ali has saved my life. She’s the BEST!!"
"Great program, I feel it has helped me more than medication alone. The staff are awesome and the process is very warm and comforting due to the staff."
"The setting is nice and comfortable and I always feel well looked after while getting my treatment. "
"Awesome , friendly, patient staff, doctor is always available "
"I feel very safe and Dr. Ali is one of the most caring doctors I have ever seen."
"I can't think of anything to improve. The setting is nice and comfortable and I always feel well looked after while getting my treatment. "
If you’ve struggled with depression and tried two or more antidepressants* in your current episode without adequate relief, talk to your provider at Allen Psychiatry to see if you have treatment-resistant depression. This treatment is covered by most insurance.
This treatment is for those with depression who have failed at least two antidepressants. Patients will be required to have someone drive them home and will need to stay in our office for two hours. The initial treatment consists of twice weekly treatments for four weeks and then treatment once weekly. Ongoing treatment is usually required.
Learn more about SPRAVATO at https://www.spravato.com/
**Spravato**, also known as esketamine, is a prescription medication approved by the FDA for adults with treatment-resistant depression or depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior. It is administered as a nasal spray in conjunction with an oral antidepressant.
Spravato works differently from traditional antidepressants. It targets the NMDA receptors in the brain as opposed to the serotonin or norepinephrine pathways. This action helps to restore neural connections in brain areas responsible for mood and emotional regulation, potentially providing relief from depression symptoms more rapidly than traditional antidepressants.
Spravato treatment is specifically designed for adults who have not responded to at least two different treatments for their current depressive episode, making it a solution for those with treatment-resistant depression. A comprehensive evaluation by a healthcare provider is necessary to determine if Spravato is an appropriate treatment option for you.
During a Spravato treatment session, you will be in a comfortable setting under the supervision of a healthcare professional. After administering the nasal spray, you will be monitored for at least 2 hours for potential side effects and to ensure your safety. The frequency of treatment sessions typically starts twice a week for the first month, followed by adjustments based on your response to the treatment.
Like all medications, Spravato can cause side effects. Common side effects include dizziness, nausea, sedation, vertigo, decreased feeling or sensitivity (hypoesthesia), anxiety, lethargy, increased blood pressure, vomiting, and feeling drunk. It's important to discuss all potential side effects with your healthcare provider before starting treatment.
Response to Spravato can vary from person to person. Some individuals may notice improvements in their symptoms within the first few weeks of treatment, while others may take longer. Continuous evaluation by your healthcare provider is essential to monitor your progress and adjust the treatment plan as needed.
Coverage for Spravato treatment varies by insurance provider and plan. It's important to check with your insurance company directly to understand your coverage and any out-of-pocket costs. Your healthcare provider's office may also assist in navigating insurance coverage and potential assistance programs.
Spravato contains esketamine, which is a derivative of ketamine, a substance that has potential for abuse. However, Spravato is administered under strict medical supervision in a healthcare setting to minimize risks of abuse and dependence. Discuss any concerns about addiction with your healthcare provider.
Due to potential side effects such as dizziness and sedation, patients are advised not to drive or operate heavy machinery until the next day after a good night's sleep. You will need to arrange for transportation home following your treatment sessions.
To begin Spravato treatment, you'll need to consult with a healthcare provider who offers Spravato in their practice. They will evaluate your medical history, current symptoms, and previous treatments to determine if Spravato is a suitable option for you. If deemed appropriate, they will discuss the treatment plan and next steps.
*Disclaimer: Last updated 2/2/24The information provided in this page is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. The details about Spravato (esketamine) treatment provided here are general in nature and may not apply to everyone. Treatment decisions should always be made on an individual basis in consultation with a healthcare professional. The efficacy and safety of treatments can vary significantly depending on individual circumstances. While we strive to provide up-to-date information, medical knowledge and guidelines change over time, and some information may become outdated. Therefore, we cannot guarantee the accuracy or completeness of the information provided. No assurance can be given regarding the insurance coverage or costs associated with Spravato treatment, as these are dependent on individual insurance plans and healthcare providers.